Diagnostic efficacy of EBUS‐TBNA in benign diseases in a population with a high prevalence of tuberculosis. Issue 3 (16th November 2020)

• Record Type: Journal Article
• Authors: Batum, Özgür; Katgı, Nuran; Özdemir, Özer; Yılmaz, Ufuk
• Is Part Of: Diagnostic cytopathology. Volume 49:Issue 3(2021)
• Page Start: 374
• Page End: 380
• Publication Date: 2020-11-16
• Subjects: cytology -- EBUS‐TBNA -- fine‐needle aspiration; Cytodiagnosis -- Periodicals; Pathology, Cellular -- Periodicals; Cytology -- Periodicals; 616.07582
• DOI: 10.1002/dc.24661
• Languages: English
• ISSNs: 8755-1039

Abstract

Abstract: Setting: Although endobronchial ultrasonography‐transbronchial needle aspiration (EBUS‐TBNA) has a well‐known place in the staging and diagnosis of lung cancer, the place of EBUS is not clear in the diagnosis of benign diseases, especially in countries with a high prevalence of tuberculosis. Aim: The aim of this study is to investigate the diagnostic efficacy of EBUS‐TBNA in benign diseases in a population with a high prevalence of tuberculosis. Material and Methods: Between October 2011 and March 2018, 1077 EBUS‐TBNA was applied. Results: The diagnosis was reached with mediastinoscopy or video assisted thoracic surgery (VATS) in 41 (74.5%) and with the second EBUS‐TBNA performed in 14 (25.5%) of 55 EBUS practices in 41 patients with malignancy diagnosis. The final diagnosis was achieved with clinical/radiological features in 7 (77.7%) cases of sarcoidosis, with VATS/mediastinoscopy in 2 (22.2%) cases, with EBUS‐TBNA performed for the second time in 6 (54.5%) tuberculosis cases and with acid‐resistance bacilli reproduction in Lowenstein‐Jensen culture in 5 (45.4%) cases. Two hundred and ninety‐five (79.7%) patients were accepted as "benign disease" due to the absence of radiological and clinical progression of lesions in the follow‐up. Conclusion: The diagnostic accuracy of EBUS‐TBNA is high in benign diseases such as sarcoidosis and tuberculosis.